Tomaszewski, Erin L.Atkinson, Mark J.Janson, ChristerKarlsson, NiklasMake, BarryPrice, DavidReddel, Helen K.NOVELTY study investigatorsNOVELTY Scientific Community2023-04-112023-04-112023-04-08Tomaszewski, E L, Atkinson, M J, Janson, C, Karlsson, N, Make, B, Price, D, Reddel, H K, NOVELTY study investigators & NOVELTY Scientific Community 2023, 'Chronic Airways Assessment Test : Psychometric properties in patients with asthma and/or COPD ', Respiratory Research, vol. 24, 106. https://doi.org/10.1186/s12931-023-02394-61465-9921PubMedCentral: PMC10082977https://hdl.handle.net/2164/20466Acknowledgements The authors would like to thank the patients who participated in this study and wish to acknowledge the work of the NOVELTY Scientific Community and the NOVELTY study investigators, who are listed in full below, and Sharon MacLachlan (Evidera, London, UK), who participated in the analysis of sections of the data. Medical writing support, under the direction of the authors, was provided by Niall Tyrer, MBiolSci, CMC Connect, a division of IPG Health Medical Communications, funded by AstraZeneca, Cambridge, UK, in accordance with Good Publication Practice (GPP 2022) guidelines (Ann Intern Med 2022; 175(9):1298–1304). Funding The NOVELTY study was funded by AstraZeneca.131172126engAsthmaCOPDpatient-reportedpsychometricschronic airways assessment testCOPD assessment testR MedicineRJournal article10.1186/s12931-023-02394-624